The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Over $200 million syndicated senior-secured revolving and term loan credit facilities to a sports and entertainment food concession operator
Represented a lead agent and lead arranger in connection with over $200 million syndicated senior-secured revolving and term loan credit facilities more
Medical malpractice
Represented a widower after his wife died due to healthcare negligence.  The case resulted in one of the largest medical malpractice settlements ever more
Trade secret, Computer Fraud and Abuse Act and Civil RICO litigation in Atlanta federal district court
Represented Alliance of Professionals & Consultants, a major temporary staffing company, in a lawsuit in federal district court in Atlanta more
Class action lawsuit involving Telephone Consumer Protection Act
Represented national telecommunications company in national class action involving alleged violations of the TCPA with exposure in excess of $50 more